Reduced subcutaneous adipogenesis in human hypertrophic obesity is linked to senescent precursor cells

Nat Commun. 2019 Jun 21;10(1):2757. doi: 10.1038/s41467-019-10688-x.

Abstract

Inappropriate expansion of the adipose cells in the subcutaneous adipose tissue (SAT) is a characteristic of hypertrophic obesity and of individuals with genetic predisposition for T2D (first-degree relatives; FDR). It is associated with insulin resistance, a dysfunctional, adipose tissue and reduced adipogenesis. We examined the regulation of adipogenesis in human SAT precursor cells and found ZNF521 to be a critical regulator of early adipogenic commitment and precursor cells leaving the cell cycle. However, neither altered upstream signalling nor lack of SAT progenitor cells could explain the reduced adipogenesis in hypertrophic obesity. Instead, we show that progenitor cells undergoing poor differentiation are characterized by senescence, inability to suppress p53/P16INK4 and secretion of factors reducing adipogenesis in non-senescent cells. We found aging, FDR and established T2D to be associated with increased progenitor cell senescence, reduced adipogenesis and hypertrophic expansion of the SAT adipose cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes
  • Adipogenesis*
  • Adult
  • Aged
  • Aging / physiology
  • Biopsy, Needle
  • Cells, Cultured
  • Cellular Senescence / physiology*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / genetics
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Hypertrophy / pathology
  • Male
  • Middle Aged
  • Obesity / etiology
  • Obesity / pathology*
  • Primary Cell Culture
  • Signal Transduction / physiology
  • Stem Cells / physiology
  • Subcutaneous Fat / cytology
  • Subcutaneous Fat / pathology*
  • Tumor Suppressor Protein p53 / metabolism
  • Young Adult

Substances

  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA-Binding Proteins
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • zinc finger protein 521, human